Diabetes in pregnancy is associated with risks to the woman and her developing fetus. Management of the condition at the primary care level includes pre-conception care, screening, diagnosis, as well as antenatal and postpartum care. A multidisciplinary approach is essential in ensuring its holistic management.

Obesity is a growing epidemic due to an accelerated phase of industrialization and urbanization with the overfed people now outnumbered the underfed. It is the major public health problem with a lot of research interest as it is associated with many complicated chronic disorders such as type-2 diabetes, cardiovascular diseases (CVD) and cancers. A global estimation of 2.8 million deaths per year is due to obesity and there are tremendous on-going efforts to identify hosts and environmental factors that infl uence the cause and pathogenesis of obesity. Concerted efforts from different research groups had successfully shown that obese subjects have altered composition of gut microbiota and transplantation of this microbiota infl uences body weight in the germ-free recipient mice. The advancement of technology had made possible the study of gut microbiota which was unculturable for better understanding of their impact to human health. Rapid deep sequencing of DNA at reasonable cost through various options of platforms followed by data analysis using robust bioinformatic tools are an important way of analysing the gut microbiome. Here we review the role of gut microbiota which modulates host’s metabolic functions and gene expression, facilitating the extraction and storage of energy from the ingested dietary substances and leading to body-weight gain. We will discuss on the different techniques used, focusing on the high-defi nition technologies for the determination of the composition, function and ecology of gut microbiota. This allows the appropriate selection of platform which becomes the key for success of subsequent research.
Obesity

Background: Adipose tissue provides an abundant source of multipotent cells, which represent a source of cell-based regeneration strategies for urinary bladder smooth muscle repair. Our objective was to confirm that adipose-derived stem cells (ADSCs) can be differentiated into smooth muscle cells. Methods: In this study, adipose tissue samples were digested with 0.075% collagenase, and the resulting ADSCs were cultured and expanded in vitro. ADSCs at passage two were differentiated by incubation in smooth muscle inductive media (SMIM) consisting of MCDB I31 medium, 1% FBS, and 100 U/mL heparin for three and six weeks. ADSCs in non-inductive media were used as controls. Characterisation was performed by cell morphology and gene and protein expression. Result: The differentiated cells became elongated and spindle shaped, and towards the end of six weeks, sporadic cell aggregation appeared that is typical of smooth muscle cell culture. Smooth muscle markers (i.e. alpha smooth muscle actin (ASMA), calponin, and myosin heavy chain (MHC)) were used to study gene expression. Expression of these genes was detected by PCR after three and six weeks of differentiation. At the protein expression level, ASMA, MHC, and smoothelin were expressed after six weeks of differentiation. However, only ASMA and smoothelin were expressed after three weeks of differentiation. Conclusion: Adipose tissue provides a possible source of smooth muscle precursor cells that possess the potential capability of smooth muscle differentiation. This represents a promising alternative for urinary bladder smooth muscle repair.
Adipose Tissue ; Stem Cells ; Muscle Cells ; Regeneration ; Urinary Bladder

Asthma is a chronic inflammatory disease of the airway which is often misdiagnosed and undertreated. Early diagnosis and vigilant asthma control are crucial to preventing permanent airway damage, improving quality of life and reducing healthcare burdens. The key approaches to asthma management should include patient empowerment through health education and selfmanagement and, an effective patient-healthcare provider partnership.

Introduction: Atopic eczema (AE) is a common infammatory skin dermatosis that is increasing in prevalence. However, it can present in various clinical presentations, which leads to challenges in the diagnosis and treatment of the condition, especially in a primary care setting. Te Clinical Practice Guidelines on the Management of Atopic Eczema was developed by a multidisciplinary development group and approved by the Ministry of Health Malaysia in 2018. It covers the aspects of diagnosis, severity assessment, treatment, and referral.

Diabetic foot requires careful attention and coordinated management by a dedicated team. Screening, prevention, adequate assessment, and appropriate referral are crucial to prevent complications. Multimodal treatment and rehabilitation are recommended to ensure a better quality of life and reduction of amputation rate in people with diabetic foot.